Coronavirus Update - 14th October 2020

Despite the recent rises in Covid-19 cases throughout the UK and Europe, Arcinova remains open for business at full capacity as we have done throughout this pandemic. As the situation continues to evolve, we will keep all our customers and stakeholders informed of our activities through this web-page which is updated on a regular basis.

We would like to take this opportunity to thank our clients and staff for their continued support over this period of restricted movement. 

We fully comply with all government guidance on minimising the risks of COVID-19 and have published our risk assessment here

Arcinova's Dr Stephen Byard Recieves Award For Service

Our Head of Molecule Development & Scientific Direction, Stephen Byard, attended the Royal Society of Chemistry awards ceremony this week, where he received his Award for Service. We are delighted that his exceptional work with the Nuclear Magnetic Resonance (NMR) Discussion Group has been recognised. The Award for Service winners are nominated by their peers for outstanding long-term non-academic contribution to the chemical sciences. Stephen has been an active member of the RSC NMR Interest Group for the last 15 years and held the role of Honorary Interest Group Secretary for a decade.


Discover how Arcinova can help

We provide a fully integrated approach to drug development, speak to our team and discover how we can help you fast forward to market.